(Q33870389)

English

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

6

object named as

Siegfried Kasper

0 references

Hans-Jürgen Möller

5

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

29 July 2017

4

object named as

John Krystal

1 reference

Europe PubMed Central

29 July 2017

1

object named as

Michael Soyka

1 reference

Europe PubMed Central

29 July 2017

Henry R. Kranzler

2

object named as

Henry R Kranzler

1 reference

Europe PubMed Central

29 July 2017

author name string

Wim van den Brink

3

1 reference

Europe PubMed Central

29 July 2017

WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders

7

1 reference

Europe PubMed Central

29 July 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

29 July 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

29 July 2017

12

1 reference

Europe PubMed Central

29 July 2017

3

1 reference

Europe PubMed Central

29 July 2017

160-187

1 reference

Europe PubMed Central

29 July 2017

A review of the community reinforcement approach in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Peptide kappa opioid receptor ligands: potential for drug development

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Alcohol use by heroin addicts: evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid Detoxification with Delta Sleep-Inducing Peptide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients--frequency and correlates of use.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opiates as antidepressants.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Mechanisms of respiratory insufficiency induced by methadone overdose in rats.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Acute opiate overdose: characteristics of 190 consecutive cases

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The effects of methadone and its role in fatalities

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Naltrexone pharmacotherapy for opioid dependent federal probationers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine induces ceiling in respiratory depression but not in analgesia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Heroin overdose: research and evidence-based intervention

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Suicide among heroin users: rates, risk factors and methods

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Cognitive impairment among methadone maintenance patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Neuropsychological deficits and opiate abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A meta-analytic review of psychosocial interventions for substance use disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Management of neonatal abstinence syndrome in neonates born to opioid maintained women

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

High dose versus moderate dose methadone maintenance: is there a better outcome?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone maintenance dosing guideline for opioid dependence, a literature review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Long-term follow-up of orally administered diacetylmorphine substitution treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Network therapy: decreased secondary opioid use during buprenorphine maintenance

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Efficacy and tolerability of naltrexone in the management of alcohol dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Qt prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Lofexidine, an {alpha}2-receptor agonist for opioid detoxification

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of Contingent Payment on Compliance with a Naltrexone Regimen

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Substance abuse and schizophrenia: pharmacotherapeutic intervention

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone maintenance improves cognitive performance after two months of treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone, buprenorphine, and street drug interactions with antiretroviral medications

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacogenetic treatments for drug addiction: alcohol and opiates.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Ventricular arrhythmias in patients treated with methadone for opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Heroin-assisted treatment for opioid dependence: Randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A 33-year follow-up of narcotics addicts

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Assessing the relationship between maternal opiate use and neonatal mortality

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The quantification of mortality resulting from the regular use of illicit opiates.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

How individual sensitivity to opiates can be predicted by gene analyses

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Use of buprenorphine in pregnancy: patient management and effects on the neonate

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Treatment of opioid-dependent pregnant women: clinical and research issues

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Side effects of levomethadone and racemic methadone in a maintenance program

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Torsade de pointes associated with very-high-dose methadone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Physician awareness of the cardiac effects of methadone: results of a national survey

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

QTc interval screening in methadone treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Stereoselective disposition of methadone in man.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Stereoselective pharmacokinetics of methadone in chronic pain patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Intermittent naloxone attenuates the development of physical dependence on methadone in rhesus monkeys

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Impulse control differences between abstinent heroin users and matched controls.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Understanding polydrug use: review of heroin and cocaine co-use

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Are mu-opioid receptor polymorphisms important for clinical opioid therapy?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

QTc interval prolongation in patients on long-term methadone maintenance therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Impact of methadone treatment on cardiac repolarization and conduction in opioid users

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Deaths of clients in methadone treatment in Texas: 1994-2002.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The effects of psychosocial services in substance abuse treatment.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Cognitive impairment in methadone maintenance patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid abuse and cognitive performance

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Diacetylmorphine versus methadone for the treatment of opioid addiction

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The impact of heroin on frontal executive functions

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Treatment guidelines for substance use disorders and serious mental illnesses: do they address co-occurring disorders?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Program factors and treatment outcomes in drug dependence treatment: an examination using meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of sublingually given naloxone in opioid-dependent human volunteers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Improvement in naltrexone treatment compliance with contingency management.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pregnancy under high-dose buprenorphine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacogenetics of opioids

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Emerging drugs to treat alcoholism

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Nalmefene for treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: clinical results from an open study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Less driving impairment on buprenorphine than methadone in drug-dependent patients?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Cognitive-motor performance of methadone-maintained patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clonidine transdermal patches for use in outpatient opiate withdrawal.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Epidemiological trends in abuse and misuse of prescription opioids

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Contingency management in a methadone maintenance program: availability of reinforcers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of buprenorphine/naloxone in opioid-dependent humans

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid dependence treatment: options in pharmacotherapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone-associated Q-T interval prolongation and torsades de pointes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Clinical experience with antagonist-induced opiate withdrawal under anaesthesia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Heroin-assisted treatment in Switzerland: a case study in policy change

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Radiopharmaceuticals in neurological and psychiatric disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Evidenced-based treatment of opioid-dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacological treatments for heroin and cocaine addiction

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Naloxone treatment in opioid addiction: the risks and benefits

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Long-term effects of heroin-assisted treatment in Germany

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Effects of buprenorphine and methadone in methadone-maintained subjects.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Successful use of naltrexone in addicted physicians and business executives.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Buprenorphine in the treatment of opiate dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

A meta-analysis comparing the effectiveness of buprenorphine and methadone.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Opioid dependence and pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Psychotherapy for opiate addicts. Does it help?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Twelve-month follow-up of psychotherapy for opiate dependence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Psychotherapy in community methadone programs: a validation study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Naltrexone-induced opiate receptor supersensitivity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Improving Treatment Outcome in Pregnant, Methadone-Maintained Women:Results from a Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.561872

21 January 2018

Identifiers

10.3109/15622975.2011.561872

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33870389&oldid=2136094575"